Three-year Single Institution Audit on Transfusion Requirements in Oncology Patients

Clinical Oncology

Volumn 19, Issue 4, 2007, Pages 223-227

  Dernedde, U ^a   Dernedde, R ^b   Shepstone, L ^c   Barrett, A ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b University of East Anglia ^*  (Germany)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Blood transfusions; chemotherapy; erythropoietin; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DOXORUBICIN; ERYTHROPOIETIN; HEMOGLOBIN; PACLITAXEL; PLATINUM COMPLEX; TOPOTECAN; TREOSULFAN;

ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BREAST CANCER; CANCER PATIENT; CLINICAL PRACTICE; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MONOTHERAPY; OVARY CARCINOMA; PANCREAS CARCINOMA; PREDICTION; PRIORITY JOURNAL; TREND STUDY; WORKLOAD;

ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DATABASE MANAGEMENT SYSTEMS; ENGLAND; ERYTHROPOIETIN; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEMOGLOBINS; HOSPITALS, UNIVERSITY; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL AUDIT; MEDICAL ONCOLOGY; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; RADIATION ONCOLOGY; UTILIZATION REVIEW;

EID: 34147106079     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.11.011     Document Type: Article

References (21)

1. Varney S.J., and Guest J.F. The annual cost of blood transfusions in the UK. Transfus Med 13 (2003) 205-218
2. Seidenfeld J., Piper M., Flamm C., et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst 93 (2001) 1204-1214
3. Rizzo J.D., Lichtin A.E., Woolf S.H., et al. American Society of Clinical Oncology. American Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20 (2002) 4083-4107
4. Bokemeyer C., Aapro M.S., Courdi A., et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 40 (2004) 2201-2216
5. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Cancer and treatment-related anemia. Version 2, 21 April 2005.
6. Barrett-Lee P.J., Bailey N.P., O'Brien M.E., and Wager E. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 82 (2000) 93-97
7. Ludwig H., Barrett-Lee P.J., Gascon P., Schneider M., and Van Belle S. European Cancer Anaemia Survey (ECAS) defines factors surrounding anaemia in thousands of adult cancer patients. Proc Am Soc Clin Oncol 21 (2002) abstract 1546
8. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34 3 Suppl. 2 (1997) 13-19
9. Demetri G.D., Kris M., Wade J., Degos L., and Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16 (1998) 3412-3425
10. Littlewood T.J., Bajetta E., Nortier J.W.R., et al. Effects of epoitin alfa on haematological parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomised, double-blind, placebo-controlled trial. J Clin Oncol 19 (2001) 2865-2874
11. Lind M., Vernon C., Cruickshank D., et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86 (2002) 1243-1249
12. Skillings J.R., Sridhar F.G., Wong C., and Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol 16 (1993) 22-25
13. Heddens D., Alberts D., Hannigan E.V., et al. Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment. Gynecol Oncol 86 (2002) 239-243
14. Coiffier B., Guastalla J.P., Pujade-Lauraine E., and Bastit P. Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey. Eur J Cancer 37 (2001) 1617-1623
15. Groopman J.E., and Loretta M.I. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91 (1999) 1616-1634
16. Abels R.I. Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematol 87 Suppl. 1 (1992) 4-11
17. Shasha D., and Harrison L.B. Anemia treatment and the radiation oncologist: optimizing patient outcomes. Oncology 15 (2001) 1486-1496
18. Seshadri T., Prince H.M., Bell D.R., et al. The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. Med J Aust 182 (2005) 453-457
19. Murphy M.F., Wallington T.B., Kelsey P., et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol 113 (2001) 24-31
20. Thatcher N., De Campos E.S., Bell D.R., et al. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer 80 (1999) 396-402
21. Drugs and Therapeutics Bulletin. Epoitins and darbepoetin alfa in malignant disease. DTB 42 (2004) 21-23